Children with germline PTPN11 mutations are at increased risk for the development of a characteristically transient JMML-like myeloproliferative disorder in infancy classified as Noonan Syndrome-associated Myeloproliferative Disease (NS-MPD) [2]. Here, PTPN11 is linked to myeloproliferative disorder.